Ruoxuan Hei
- Topics
- Cancer-related molecular mechanisms research (4 papers)Osteoarthritis Treatment and Mechanisms (4 papers)RNA modifications and cancer (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Ruoxuan Hei
12 papers receiving 289 citations
Hit Papers
Peers
Comparison fields: 5 of 61
- Molecular Biology 150
- Oncology 126
- Pulmonary and Respiratory Medicine 86
- Cancer Research 55
- Cell Biology 36
Countries citing papers authored by Ruoxuan Hei
This map shows the geographic impact of Ruoxuan Hei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruoxuan Hei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruoxuan Hei more than expected).
Fields of papers citing papers by Ruoxuan Hei
This network shows the impact of papers produced by Ruoxuan Hei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruoxuan Hei. The network helps show where Ruoxuan Hei may publish in the future.
Co-authorship network of co-authors of Ruoxuan Hei
This figure shows the co-authorship network connecting the top 25 collaborators of Ruoxuan Hei. A scholar is included among the top collaborators of Ruoxuan Hei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruoxuan Hei. Ruoxuan Hei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | Construction and experimental validation of a necroptosis-related lncRNA signature as a prognostic model and immune-landscape predictor for lung adenocarcinoma. | 0 |
| 4 | 10 | |
| 5 | CircCRIM1 suppresses osteosarcoma progression via sponging miR146a-5p and targeting NUMB. | 3 |
| 6 | Macrophage polarization involved the inflammation of chronic obstructive pulmonary disease by S1P/HDAC1 signaling. | 12 |
| 7 | Mef2a is a positive regulator of Col10a1 gene expression during chondrocyte maturation. | 4 |
| 8 | Stat5a promotes Col10a1 gene expression during chondrocyte hypertrophic differentiation. | 2 |
| 9 | CircNRIP1 acts as a sponge of miR-1200 to suppress osteosarcoma progression via upregulation of MIA2. | 3 |
| 10 | Integrated analyses of an RNA binding protein-based signature related to tumor immune microenvironment and candidate drugs in osteosarcoma. | 8 |
| 11 | 10 | |
| 12 | CDK inhibitors in cancer therapy, an overview of recent development.breakdown → | 219 |
| 13 | DLX5 promotes osteosarcoma progression via activation of the NOTCH signaling pathway. | 13 |
| 14 | 2 |
About Ruoxuan Hei
Ruoxuan Hei is a scholar working on Cancer Research, Rheumatology and Immunology and Allergy, having authored 14 papers that have together received 292 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Oncology (126 citations), Cancer Research (55 citations) and Pulmonary and Respiratory Medicine (86 citations). Ruoxuan Hei has collaborated with scholars based in China and United States. Frequent co-authors include Qiping Zheng, Cheguo Cai, Xiao Li, Lingxian Zhang, Xuan Wu, Biaohua Chen, Yaojuan Lu, Junxia Gu, Yanwei Chen and Xi Liu. Their work appears in journals such as ACS Applied Materials & Interfaces, Frontiers in Genetics and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.